Heart failure

1

Tamás Fenyvesi MD3rd Department of Medicine2016 , November

Circulatory failure

Heart

Insufficient oxygen and nutrient supply to the tissues,and cells+ insufficient removal of the metabolic endproducts

2

+ insufficient removal of the metabolic endproducts causes:

cardiac extracardiac1.decreased venous return2.increased vascular capacity3.decreased oxyhemoglobin

Heart failure:the heart is unable to pump sufficient blood , provided the

venous return is normal

mechanical myocardial1. pressure overload 1. ischaemic heart disease

AS, hypertension diffuse or segmental

3

2. volume overload 2. myocardial diseasevalvular regurg.,shunts

3. insufficient fillingmitral or tricuspid

stenosis4. Pericardial disease

Classifications of impaired ventricular fuction

1. Forward failure vs backward failure2. Left heart failure vs right heart failure3. Systolic vs diastolic dysfunction

4

3. Systolic vs diastolic dysfunction4. Acute vs chronic5. Low output vs high output

“Backward” failure

James Hope 18321. ventricular volume and pressure2. atrial volume and pressure behind the failing ventricle3. atrial contraction

5

3. atrial contraction4. venous pressure 5. capillary pressure6. transsudation into the interstitial tissue7. extracellular fluid volume

“Forward failure”Sir James Mackenzie 1913

decreased cardiac output:kidneys sodium retention

6

kidneys sodium retention(RAS activation)

liver dysfunctionmuscular weakness, fatiguebrain confusion

„left” or „right” heart failure

This is implicitly „backward failure”congestion behind the originally failing ventricle

7

left ventricle pulmonary congestion,pulm edema

right ventricle liver and peripheralcongestion oedema etc

Acute heart failure

The sudden development of the syndromeno time for compensatory mechanisms to activate

massive myocardial infarction

8

massive myocardial infarctionheart block with very slow ventricular rate< 35/mintachyarrhythmia with very rapid rate > 180/minrupture of a valveocclusion of a large segment of pulmonary artery

sudden reduction of cardiac output

stroke volume

symp PRA

catechol vasoconstr AII

9

catechol vasoconstr AII

prostaglandin bradykinin vasopressin aldosteronedilate dilate constr constr

constrictor > dilatator

Low-output vs high-output failure

1. Low output is the typical: most of the heart diseasesimpaired peripheral circulation, cold, pale or cyanotic extremities

2. High output: cardiac output is high before the development

10

2. High output: cardiac output is high before the developmentof failure

anaemia, hyperthyroidismAV shunts, Paget’s disease, Beriberi (B1 vit defic)gravidityhot, hyperemic extremities

Compensatory mechanismsExtracardiac cardiacpreload

afterloadnatriuresis

volume decomp

11

volume decomp atrial dilat vasodilat

vasoconstr cardiac output ANP

RASsymp,ADH

RBF GFR FFsodium retention

12

13

14

15

ACC Heart Failure GuidelinesSlide Deck

Based on the ACC/AHA 2005 Guideline Update

16

for the Diagnosis and Management of Chronic Heart Failure in the Adult

January 2006

Definition of Heart Failure

HF is a complex clinical syndrome that canresult from any structural or functional

17

cardiac disorder that impairs the ability ofthe ventricle to fill with or eject blood.

“Heart Failure” vs. “Congestive Heart Failure”

Because not all patients have volume overload atthe time of initial or subsequent evaluation, theterm “heart failure” is preferred over the older

18

term “heart failure” is preferred over the older term “congestive heart failure.”

Causes of HF in Western World

For a substantial proportion of patients, causes are:

1. Coronary artery disease

19

1. Coronary artery disease

2. Hypertension

3. Dilated cardiomyopathy

Class I —No limitation: Ordinary physical activity does notcause undue fatigue, dyspnea, or palpitation.

Class II —Slight limitation of physical activity:Such patients are comfortable at rest.Ordinary physical activity results in fatigue, palpitation dyspnea, or angina.

Class III —Marked limitation of physical activity:

NYHA Classification of HF

20

Class III —Marked limitation of physical activity:Although patients are comfortable at rest, less than ordinary activity will lead to symptoms.

Class IV —Inability to carry on any physical activity without discomfort: Symptoms of congestivefailure are present even at rest. With any physical activity, increased discomfort isexperienced.

Stages of Heart Failure

At Risk for Heart Failure:

STAGE A High risk for developing HF

STAGE B Asymptomatic LV dysfunction

21

STAGE B Asymptomatic LV dysfunction

Heart Failure:

STAGE C Past or current symptoms of HF

STAGE D End-stage HF

Stage A

Patients at High Risk for Developing Heart Failure

22

Developing Heart Failure

Stage B

Patients with Asymptomatic LV Dysfunction

23

LV Dysfunction

Stage C

Patients with Past or CurrentSymptoms of Heart Failure

24

Symptoms of Heart Failure

Stage D

Patients with Refractory End -Stage HF

25

Stage D Therapy

Options for end-of-life care should be discussed with the patient and family when severe symptoms in patients with refractory

Discussion of Options for End-of-Life Care

III IIaIIaIIa IIbIIbIIb IIIIIIIIIIII IIaIIaIIa IIbIIbIIb IIIIIIIIIIII IIaIIaIIa IIbIIbIIb IIIIIIIIIIIaIIaIIa IIbIIbIIb IIIIIIIII

26

severe symptoms in patients with refractory end-stage HF persist despite application of all recommended therapies.

27

28

Stages of Heart Failure

COMPLEMENT, DO NOT REPLACE NYHA CLASSES

• NYHA Classes - shift back/forth in individual patient (in response to Rx and/or progression of

29

patient (in response to Rx and/or progression of disease)

• Stages - progress in one direction due to cardiac remodeling

Differential Diagnosis in Patient with HF and Normal LVEF with Symptoms

• Incorrect diagnosis of HF• Inaccurate measurement of

LVEF• Primary valvular disease• Restrictive (infiltrative)

cardiomyopathies

• HF associated with high metabolic demand (high-output states)

• Anemia, thyrotoxicosis, arteriovenous fistulae

• Chronic pulmonary

30

cardiomyopathies• Amyloidosis, sarcoidosis,

hemochromatosis• Pericardial constriction• Episodic or reversible LV

systolic dysfunction• Severe hypertension,

myocardial ischemia

• Chronic pulmonary disease with right HF

• Pulmonary hypertension associated with pulmonary vascular disorders

• Atrial myxoma• Diastolic dysfunction of

uncertain origin• Obesity

31

32

BNP - echodyspnea

BNP - echodyspnea

EKG, RTG, BNP

<100 100-500 >500 pg/ml

EKG, RTG, BNP

<100 100-500 >500 pg/ml

33

<100 100-500 >500 pg/ml

HF echo: LVD HF 95%unlikely COPD echo

PE

<100 100-500 >500 pg/ml

HF echo: LVD HF 95%unlikely COPD echo

PE

Maisel Rev CV Med 2003;4:S3-12Maisel Rev CV Med 2003;4:S3-12

Systolic vs diastolic heart failure

Implicit in the physiological definition the defect to pumpadequate volume of blood is a systolic heart failure

the abnormality may be caused by a defect ofventricular filling i.e. diastolic heart failure

34

ventricular filling i.e. diastolic heart failureslowed or incomplete ventricular relaxation

possible causes:acute or chronic ischaemiaconcentrical hypertrophyrestrictive cardiomyopathy

most clinical manifestations are combined

Diastolic dysfunctionFibrosis Cellular dysarray PassiveHypertrophy chamber

stiffnessAsynchrony Diastolic

35

Asynchrony DiastolicAbnormal loading pressureIschemia RelaxationAbnormal Ca++ flux

Diastolic heart failure became a centralissue of cardiology.

Diastolic heart failure is heart failure with preserved systolic function

36

with preserved systolic functionor normal ejection fraction (HFNEF)EF>50%

Systole and diastole

“So that the coming together,

depends on the going apart,

38

depends on the going apart,

the systole depends on the diastole;

the flow depends on the ebb.”

DH Lawrence

Symptoms of heart failure

1.dyspnea2.fatigue and weakness

hypoperfusion of the sceletal musculaturehyponatremia caused by diuretics

39

hyponatremia caused by diuretics3.nocturia

redistribution of cardiac output at night: RBF4.liver distension

epigastrial dyscomfort

General mechanisms of dyspnoe:left atrial pressure

pulmonary capillary pressure

interstitial fluid volume in the lungs

40

elasticity of the lung

increased work of breathing low cardiac output impaired perfusion of the respiratory

muscles fatigue sensation of dyspnoe

Physical signs of heart failure1

•visible dyspnoe •gray color of the face•cold extremities and acrocyanosis •decreased pulse pressure•extension of the veins (jugular)

41

•extension of the veins (jugular) •palpable liver •symmetrical edema (pitting)

ankle-sacral-generalized•ascites•hydrothorax •rales „moist” at the end of inspiration

42

RAGACSKA IMRE, LM20080822104759048.avi

Physical signs of heart failure 2

tachycardiapulsus alternans ?

auscultation of the heart

43

auscultation of the heartS3 gallopaccentuated P2syst murmur- tricusp regurg

cardiac cachexia

Pulsus alternans

44this is just an interesting possibility

Framingham criteria for congestive heart failure

Major criteria:paroxysmal nocturnal dyspnea or orthopneaneck vein distensionrales

45

ralescardiomegalyacute pulmonary edemaS3 gallopincreased venous pressure > 16cm H2Ocirculation time > 25 sechepatojugular reflux

Framingham criteria for congestive heart failure

Minor criteria: ankle edemanight coughdyspnea on exertion

46

dyspnea on exertionhepatomegalypleural effusionvital capacity 1/3 from maximumtachycardia > 120/min

Minor or major criterion:weight loss > 4,5 kg in 5 days in

response to treatment

The main causes of heart failureIschaemic heart disease !!

myocardial infarction necrosisremodeling

Systemic hypertension LV hypertrophy

47

Systemic hypertension LV hypertrophy

Valvular heart disease pressure load, ASvolume load AI

Cardiomyopathies obstructivedilatativerestrictive

Algoritm of diagnostic approach to HF

Suspition of HF

EKG,,RTG, BNP

Dg. rejected

abnormal

norm

48

abnormal

echocardiography

Cause,type,severity?

abnormal

therapy

additional Workup, eg.

coronarography

norm

Epidemiology of heart failure~ 4 million pts in the USA

yearly incidence > 400.000 hospitalization 1000 000

most prevalent cause of death > 300.000Hospital mortality 30-50% / year

49

Hospital mortality 30-50% / yearin the mixed population

5 years survival afterdiagnosis only 25% in men and

38% in womenyearly cost 22billion $

Annual incidence of heart failure per 1000 population in

Framingham

2831

20

25

30

35

50

1 2 35 6

9

13

17

0

5

10

15

20

45-54 55-64 65-74 75-84 85-94

femalemale

Prevalence of heart failure

51

Prevalence of HFPrevalence of HF

9

SpainSpain

Den.Copen.6,4

Den.Copen.6,4

SvedenVästeras6,7

SvedenVästeras6,7

EnglandPoole7,5

EnglandPoole7,5

FinlandHelsinki8,2

FinlandHelsinki8,2

USACHS8,8

USACHS8,8 proportion with preserved

LV systolic function

proportion with preserved

LV systolic function

Overall 2.5% in the communitySenni, Circ 1998; 98:2282

Overall 2.5% in the communitySenni, Circ 1998; 98:2282

52

4,8 4,25,1

3,14,5

2,91,7 1,23 1,5

0

3

6

Nether.Rotter.2,1

Nether.Rotter.2,1

USAOlmsted2,2

USAOlmsted2,2

PortugalEPICA4,2

PortugalEPICA4,2

SpainAsturias4,9

SpainAsturias4,9

6,46,4

Age(years) 66-103 75-86 70-84 75 ≥50 >40 >25 >44 55-95Mean 78 - 76 75 - 60 68 63 65Age(years) 66-103 75-86 70-84 75 ≥50 >40 >25 >44 55-95Mean 78 - 76 75 - 60 68 63 65

Hogg JACC 2004; 43:317Hogg JACC 2004; 43:317

53

2016 ESC Guidelines for the diagnosis andtreatment of acute and chronic heart failureThe Task Force for the diagnosis and treatment of acute and chronicheart failure of the European Society of Cardiology (ESC)

54

Cardiology (ESC)Developed with the special contribution of the Heart FailureAssociation (HFA) of the ESC

THE END!

55

56

57

58

2016 ESC Guidelines for the diagnosis andtreatment of acute and chronic heart failureThe Task Force for the diagnosis and treatment of acute and chronicheart failure of the European Society of Cardiology (ESC)

59

Cardiology (ESC)Developed with the special contribution of the Heart FailureAssociation (HFA) of the ESCAuthors/Task

60

61